Geode Capital Management
OBX icon

Geode Capital Management’s Obsidian Therapeutics OBX Stock Holding History

Geode Capital Management’s Portfolio OBX Stock Details OBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.64M Buy
+483,438
New +$9.44M ﹤0.01% 2696

Other funds holding OBX

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Revelation Capital Management
Revelation Capital Management Sausalito, California $8.01M AUM 49.3% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Geode Capital Management's OBX Position: Q3 2026 in Review

Geode Capital Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 483,438 shares worth $6.64M. The stake represents ﹤0.01% of the portfolio and ranks #2696 among its holdings.

8 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • Geode Capital Management held 483,438 shares of Obsidian Therapeutics worth $6.64M as of Q3 2026.
  • Obsidian Therapeutics was a new Geode Capital Management position in Q3 2026.
  • Obsidian Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2696 holding.
  • 8 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.